⌘K
Loading ticker…
As of 2026-08-24, Cel-Sci Corporation (CVM) has a 3-month relative strength percentile of 42 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 33. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.7%, relative volume 0.70×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CVM is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $504K notional.
Held by 2 ETFs · $759K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $504K | — |
| VXFVanguard Extended Market ETF | 0.00% | $255K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CVM Jan avg: 6.14% median: 7.89% win: 75% σ: 6.44% n: 4 2022-04-12 → 2026-07-31 | CVM Feb avg: -18.84% median: -20.86% win: 0% σ: 10.17% n: 4 2022-04-12 → 2026-07-31 | CVM Mar avg: -17.17% median: -16.41% win: 0% σ: 12.08% n: 4 2022-04-12 → 2026-07-31 | CVM Apr avg: -6.20% median: -9.05% win: 20% σ: 19.55% n: 5 2022-04-12 → 2026-07-31 | CVM May avg: -20.29% median: -17.12% win: 40% σ: 43.09% n: 5 2022-04-12 → 2026-07-31 | CVM Jun avg: -0.77% median: 0.42% win: 60% σ: 20.57% n: 5 2022-04-12 → 2026-07-31 | CVM Jul avg: 43.45% median: -2.59% win: 40% σ: 120.66% n: 5 2022-04-12 → 2026-07-31 | CVM Aug avg: 3.34% median: -0.78% win: 50% σ: 17.30% n: 4 2022-04-12 → 2026-07-31 (current) | CVM Sep avg: -11.32% median: -10.93% win: 0% σ: 8.09% n: 4 2022-04-12 → 2026-07-31 | CVM Oct avg: 0.93% median: -1.88% win: 50% σ: 24.87% n: 4 2022-04-12 → 2026-07-31 | CVM Nov avg: 1.46% median: -3.11% win: 50% σ: 28.21% n: 4 2022-04-12 → 2026-07-31 | CVM Dec avg: -17.67% median: -26.15% win: 25% σ: 26.79% n: 4 2022-04-12 → 2026-07-31 |